CAS: 1125780-41-7 - SKLB610
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
SKLB 610 REF: AN-AG008TJJCAS: 1125780-41-7 | ≥98% | 53,00 €~166,00 € | Mar 07 May 24 | |
SKLB 610 REF: TM-T1895CAS: 1125780-41-7 | 99.30% | 36,00 €~1.006,00 € | Mar 14 May 24 | |
SKLB 610 REF: 3D-FS100095CAS: 1125780-41-7 | Min. 95% | A consultar | Mar 18 Jun 24 |
Ref: AN-AG008TJJ
5mg | 53,00 € | |
10mg | 79,00 € | |
25mg | 104,00 € | |
50mg | 145,00 € | |
100mg | 166,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
SKLB 610
CAS:1125780-41-7
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a …
Fórmula:
C21H16F3N3O3
Pureza:
99.30%
Forma y color:
Solid
Peso molecular:
415.37
Ref: TM-T1895
1mg | 36,00 € | |
5mg | 69,00 € | |
10mg | 119,00 € | |
25mg | 218,00 € | |
50mg | 322,00 € | |
100mg | 476,00 € | |
200mg | 677,00 € | |
500mg | 1.006,00 € | |
1ml*10 (DMSO) | 104,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
SKLB 610
CAS:1125780-41-7
SKLB 610 is a potential anticancer agent that inhibits tumor growth. SKLB 610 has shown …
Fórmula:
C21H16F3N3O3
Pureza:
Min. 95%
Peso molecular:
415.37 g/mol
Ref: 3D-FS100095
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024